The Partners Insurance Rx Solutions Analytics Predictive Model program has changed the pharmaceutical procurement industry with our latest innovation, Average Script Price Guaranteed contracts.

Average Script Price Guarantees

• transfer the risk for drug price inflation from the employer to the PBM;
• are equivalent to aggregate reinsurance with no premium;
• fix your Rx cost and allow for accurate budgeting;
• eliminate PBM conflict of interest on drug manufacturer rebates;
• eliminate Average Wholesale Price (AWP) and formulary bias;
• create real competition in the market and allow bidders to compete using actual claims cost as the basis of their bids.
   

The Partners Insurance Rx Solutions Analytics program through Average Script Price contracts will create significant savings for your company.

• Audits on contract compliance can be run monthly, quarterly or annually and no self reporting by the PBM.
• The winning PBM guarantees the financial performance of their bid on a first dollar basis with no cap.
• No plan design changes and no disruption of retail pharmacy access to your employees.
• Our program provides a level playing field and takes the "games" out of the RFP process.
• Program fees paid by winning bidder and all the savings go directly to the employer's bottom line.
• Fully or self insured employers with 1000+ employees or at least $1 million in prescription spending qualify.

Contact Morgan Pile at 877-491-9279 to take control of your RX spending!

Benefits Roundtable Webinar Series
Earlier this year, the Centers for Medicare & Medicaid Services (CMS), the Federal Trade Commission (FTC), the Department of Justice (DOJ) and the HHS Office of the Inspector General (OIG) issued proposed regulations dealing with the Medicare shared savings program, also known as accountable care organizations (ACOs) under Section 3022 of the Affordable Care Act of 2010.
 
Under the proposed rules, eligible providers, hospitals, and suppliers that participate in the shared savings program by creating or joining an ACO can continue to receive traditional Medicare fee-for-service payments under Medicare Parts A and B and qualify for additional payments based upon specified quality and savings requirements. This Webinar will analyze the proposed rule as well as the calls being made by several groups for changes to it. Among other things, the Webinar will address:

• The complexity of the program and what appears to be a bias against medical group participation.
• The excessively high cost of both ACO development and ongoing operation relative to the potential financial benefits.
• The small and uncertain financial benefits.
• The substantial regulatory risks under related joint notices from CMS and the Office of Inspector General (OIG), and the Federal Trade Commission (FTC) and the Department of Justice (DOJ) that deal with antitrust and fraud and abuse enforcement.
  

  CMS' part of the final rules are due to be issued within the next several weeks.
   
  Date: Wednesday, October 5, 2011
  Time: Noon - 12:40 PM CST
  Registration: Click Here